A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: UFT (uracil, tegafur)|DRUG: cyclophosphamide, methotrexate, and fluorouracil
Sponsor: Taiho Pharmaceutical Co., Ltd.